Sanofi (France) Signs $315 Million Deal with Kyowa Hakko

PARIS, May 14 (Reuters) - Sanofi-Aventis (SASY.PA) has signed a licensing deal with Kyowa Hakko Kirin (4151.T) to develop the Japanese drugmaker's inflammation treatment as part of its strategy to fill its pipeline of drugs in development.